GlassScriptPhysician profile
Harold T Peart
NPI 1720130784
$1,014.75
in general payments reported to CMS, 2019-2025
17 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $60.51 · 2021: $196 · 2022: $47.67 · 2023: $51.81 · 2024: $21.08 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $369.63 | 2019-2021 | |
| Ucb, INC. | $146.01 | 2025 | Bimzelx |
| Hologic Sales and Service, LLC | $68.93 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $53.68 | 2019-2025 | |
| Evofem Biosciences, INC. | $52.44 | 2021-2022 | |
| Sage Therapeutics, LLC | $46.64 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $44.66 | 2021-2022 | |
| Therapeuticsmd, INC. | $34.93 | 2020-2021 | |
| Abbott Laboratories | $26.81 | 2021 | |
| Shield Therapeutics INC | $25.81 | 2023 | Accrufer |
| Roche Diagnostics Corporation | $23.26 | 2021 | |
| Dexcom, INC. | $22.87 | 2025 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $21.64 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $21.13 | 2025 | Gardasil 9 |
| Amgen INC. | $21.08 | 2024 | Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $20.66 | 2020 | |
| Avion Pharmaceuticals | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Peart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.